NeuroVision Imaging is a company developing digital imaging and diagnostic solutions for identifying retinal pathology related to Alzheimer’s disease. It develops an investigational device to measure retinal autofluorescence. NeuroVision implements image processing and machine learning algorithms to quantify eye pathology as an evaluation of amyloid status in the central nervous system.